For Rocket Lab, the fastest mission in space history turned out to be a slow burn for investors. The company delivered a spacecraft for the U.S. Space Force in just 16 hours and 42 minutes from order to liftoff — beating Firefly Aerospace’s prior record by more than ten hours. Yet that achievement did nothing to stop a share price slide that has wiped out 37% of the stock’s value over the past month.
The VICTUS HAZE mission was a landmark for the Long Beach-based firm. Rocket Lab acted as the prime contractor for the first time, building the Pioneer spacecraft itself, integrating the payload, and controlling the vehicle. The entire system was fully operational in orbit within 38 hours of the launch order, slashing the 72-hour window the Space Force had set. “We set a new standard for responsive space,” the company said of the $32 million project.
But the market wasn’t listening. The stock closed at $85.41 on Wednesday after sliding 10.21% — a drop triggered by a separate disclosure: a $3 billion equity offering program that caught analysts off guard. That sell-off added to a brutal run that began in early June when SpaceX went public and ended Rocket Lab’s status as the only pure-play launch-vehicle stock available to investors. On SpaceX’s debut day alone, Rocket Lab shares fell 8%. The sector giant now commands a market cap of roughly $2.1 trillion, dwarfing Rocket Lab and pulling capital away from the smaller player.
Insider sales have compounded the pressure. Management has unloaded about $24 million worth of shares over the past three months, including a $9.5 million sale by chief legal officer Arjun Kampani in mid-June. The stock, quoted around €77.60 in European trading, now sits 42% below its 52-week high from May.
Should investors sell immediately? Or is it worth buying Rocket Lab?
The valuation math has turned harsh. Rocket Lab trades at 45 times revenue with 41% expected growth — a premium that looks less compelling with SpaceX on the buy list. A $3 billion stock sale program will further dilute existing holders, making the near-term picture even murkier. Yet not every analyst is fleeing. Michael Leshock of KeyBanc Capital Markets upgraded the stock to “Buy” following the sell-off, setting a $135 price target. He called the correction an attractive entry point, arguing the market has overshot the downside.
Operationally, the business has never looked stronger. First-quarter revenue reached roughly $200 million, and the backlog hit a record $2.2 billion. Management guided for second-quarter sales of up to $240 million. Over the trailing twelve months, however, the company has burned through $183 million in net losses on revenue of about $680 million. Cash on hand stands at $1.38 billion, but free cash flow remains deep in negative territory as Rocket Lab pours capital into the next-generation Neutron rocket.
The company has applied for launch permits for Neutron with the Federal Aviation Administration, with a launch window opening July 1, 2026. A successful first flight could restore investor confidence and unlock the heavy-lift market where it must compete head-to-head with SpaceX. For now, Rocket Lab finds itself in a peculiar moment: setting speed records in orbit while racing to win back a skeptical Wall Street.
Ad
Rocket Lab Stock: Buy or Sell?! New Rocket Lab Analysis from June 25 delivers the answer:
The latest Rocket Lab figures speak for themselves: Urgent action needed for Rocket Lab investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 25.
Rocket Lab: Buy or sell? Read more here...
